ARCHIVES

NCI T BE More Flexible In Funding RFAs Above Paylines

This article is from The Cancer Letter archive.

Vol. 15 No. 25 | June 23, 1989

Download PDF Visit The Full Archive

Related Articles

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report

May 12, 2000

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010